These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 26287601)
1. NCOA1 promotes angiogenesis in breast tumors by simultaneously enhancing both HIF1α- and AP-1-mediated VEGFa transcription. Qin L; Xu Y; Xu Y; Ma G; Liao L; Wu Y; Li Y; Wang X; Wang X; Jiang J; Wang J; Xu J Oncotarget; 2015 Sep; 6(27):23890-904. PubMed ID: 26287601 [TBL] [Abstract][Full Text] [Related]
2. NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis. Qin L; Wu YL; Toneff MJ; Li D; Liao L; Gao X; Bane FT; Tien JC; Xu Y; Feng Z; Yang Z; Xu Y; Theissen SM; Li Y; Young L; Xu J Cancer Res; 2014 Jul; 74(13):3477-88. PubMed ID: 24769444 [TBL] [Abstract][Full Text] [Related]
3. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis. Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336 [TBL] [Abstract][Full Text] [Related]
4. Steroid receptor coactivator-1 upregulates integrin α₅ expression to promote breast cancer cell adhesion and migration. Qin L; Chen X; Wu Y; Feng Z; He T; Wang L; Liao L; Xu J Cancer Res; 2011 Mar; 71(5):1742-51. PubMed ID: 21343398 [TBL] [Abstract][Full Text] [Related]
5. TRPS1 expression promotes angiogenesis and affects VEGFA expression in breast cancer. Hu J; Su P; Jia M; Wu X; Zhang H; Li W; Zhou G Exp Biol Med (Maywood); 2014 Apr; 239(4):423-9. PubMed ID: 24595984 [TBL] [Abstract][Full Text] [Related]
6. Hypoxia induces miR-153 through the IRE1α-XBP1 pathway to fine tune the HIF1α/VEGFA axis in breast cancer angiogenesis. Liang H; Xiao J; Zhou Z; Wu J; Ge F; Li Z; Zhang H; Sun J; Li F; Liu R; Chen C Oncogene; 2018 Apr; 37(15):1961-1975. PubMed ID: 29367761 [TBL] [Abstract][Full Text] [Related]
7. Krüppel-like factor 8 regulates VEGFA expression and angiogenesis in hepatocellular carcinoma. Cheng S; Zhang X; Xu Y; Dai X; Li J; Zhang T; Chen X Sci Rep; 2018 Nov; 8(1):17415. PubMed ID: 30479372 [TBL] [Abstract][Full Text] [Related]
8. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma. Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231 [TBL] [Abstract][Full Text] [Related]
9. The oncoprotein HBXIP enhances angiogenesis and growth of breast cancer through modulating FGF8 and VEGF. Liu F; You X; Wang Y; Liu Q; Liu Y; Zhang S; Chen L; Zhang X; Ye L Carcinogenesis; 2014 May; 35(5):1144-53. PubMed ID: 24464787 [TBL] [Abstract][Full Text] [Related]
11. Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription. Zou G; Zhang X; Wang L; Li X; Xie T; Zhao J; Yan J; Wang L; Ye H; Jiao S; Xiang R; Shi Y Theranostics; 2020; 10(15):6839-6853. PubMed ID: 32550907 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of histone deacetylase SIRT1 exerts an antiangiogenic role in diabetic retinopathy via miR-20a elevation and YAP/HIF1α/VEGFA depletion. Pan Q; Gao Z; Zhu C; Peng Z; Song M; Li L Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E932-E943. PubMed ID: 32776826 [TBL] [Abstract][Full Text] [Related]
13. SOHLH2 Suppresses Angiogenesis by Downregulating HIF1α Expression in Breast Cancer. Cui W; Xiao Y; Zhang R; Zhao N; Zhang X; Wang F; Liu Y; Zhang X; Hao J Mol Cancer Res; 2021 Sep; 19(9):1498-1509. PubMed ID: 34158392 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth. Zhou B; Ma R; Si W; Li S; Xu Y; Tu X; Wang Q Cancer Lett; 2013 Jun; 333(2):159-69. PubMed ID: 23352645 [TBL] [Abstract][Full Text] [Related]
16. The histone deacetylase HDAC1 activates HIF1α/VEGFA signal pathway in colorectal cancer. Chen C; Wei M; Wang C; Sun D; Liu P; Zhong X; He Q; Yu W Gene; 2020 Sep; 754():144851. PubMed ID: 32525044 [TBL] [Abstract][Full Text] [Related]
17. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers. Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034 [TBL] [Abstract][Full Text] [Related]
18. Rnd3/RhoE Modulates Hypoxia-Inducible Factor 1α/Vascular Endothelial Growth Factor Signaling by Stabilizing Hypoxia-Inducible Factor 1α and Regulates Responsive Cardiac Angiogenesis. Yue X; Lin X; Yang T; Yang X; Yi X; Jiang X; Li X; Li T; Guo J; Dai Y; Shi J; Wei L; Youker KA; Torre-Amione G; Yu Y; Andrade KC; Chang J Hypertension; 2016 Mar; 67(3):597-605. PubMed ID: 26781283 [TBL] [Abstract][Full Text] [Related]
19. Down-regulation of CITED2 attenuates breast tumor growth, vessel formation and TGF-β-induced expression of VEGFA. Jayaraman S; Doucet M; Kominsky SL Oncotarget; 2017 Jan; 8(4):6169-6178. PubMed ID: 28008154 [TBL] [Abstract][Full Text] [Related]
20. Beyond proliferation: KLF5 promotes angiogenesis of bladder cancer through directly regulating VEGFA transcription. Gao Y; Wu K; Chen Y; Zhou J; Du C; Shi Q; Xu S; Jia J; Tang X; Li F; Hui K; He D; Guo P Oncotarget; 2015 Dec; 6(41):43791-805. PubMed ID: 26544730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]